Mario Feldman
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$1.1MFederal grants as PI4 awards
3Patents grantedLatest Nov 15, 2022
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $1.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 6, 2020 | NIH | STTR Phase I Development of a bioconjugate vaccine against Group B Streptococcus | $280K | VAXNEWMO, LLC |
| Mar 11, 2019 | NIH | STTR Phase I Development of a bioconjugate vaccine against Group B Streptococcus | $300K | VAXNEWMO, LLC |
| Dec 20, 2017 | NIH | STTR Phase I Glycoengineering a bioconjugate vaccine against Klebsiella pneumoniae | $300K | VAXNEWMO, LLC |
| Feb 22, 2017 | NIH | STTR Phase I Towards a New Generation of Glycoengineered Pneumococcal Bioconjugate Vaccines | $210K | VAXNEWMO, LLC |
4 patents as inventor
- US 10265391VAXNEWMO, LLCApr 23, 2019
- US 10869918VAXNEWMO, LLCDec 22, 2020
- US 11497804VAXNEWMO, LLCNov 15, 2022
- US VAXNEWMO, LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,674
Awards as PI#566
Patents#63
Companies
- VAXNEWMO, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.